Tomas J. Heyman, Director at Akero Therapeutics, Inc. (AKRO), sold 26,000 shares at $54.67 ($1.4M) on 2023-06-16, disclosed to the SEC on 2023-06-21.
Open-market sale of $1.4M AKRO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.